193 related articles for article (PubMed ID: 31321652)
1. Could two-dimensional radial strain be considered as a novel tool to identify pre-clinical hypertrophic cardiomyopathy mutation carriers?
Santambrogio GM; Maloberti A; Vallerio P; Peritore A; Spanò F; Occhi L; Musca F; Belli O; De Chiara B; Casadei F; Facchetti R; Turazza F; Manfredini E; Giannattasio C; Moreo A
Int J Cardiovasc Imaging; 2019 Dec; 35(12):2167-2175. PubMed ID: 31321652
[TBL] [Abstract][Full Text] [Related]
2. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
[TBL] [Abstract][Full Text] [Related]
3. Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy.
Revera M; van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC
Cardiovasc Res; 2008 Mar; 77(4):687-94. PubMed ID: 18029407
[TBL] [Abstract][Full Text] [Related]
4. Myocardial Deformation Analysis in
Höller V; Seebacher H; Zach D; Schwegel N; Ablasser K; Kolesnik E; Gollmer J; Waltl G; Rainer PP; Verheyen S; Zirlik A; Verheyen N
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680864
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
[TBL] [Abstract][Full Text] [Related]
6. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
[TBL] [Abstract][Full Text] [Related]
7. Subclinical echocardiographic abnormalities in phenotype-negative carriers of myosin-binding protein C3 gene mutation for hypertrophic cardiomyopathy.
De S; Borowski AG; Wang H; Nye L; Xin B; Thomas JD; Tang WH
Am Heart J; 2011 Aug; 162(2):262-267.e3. PubMed ID: 21835286
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy.
Tarkiainen M; Sipola P; Jalanko M; Heliö T; Laine M; Järvinen V; Häyrinen K; Lauerma K; Kuusisto J
J Cardiovasc Magn Reson; 2016 Jun; 18(1):33. PubMed ID: 27259862
[TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.
Velicki L; Jakovljevic DG; Preveden A; Golubovic M; Bjelobrk M; Ilic A; Stojsic S; Barlocco F; Tafelmeier M; Okwose N; Tesic M; Brennan P; Popovic D; Ristic A; MacGowan GA; Filipovic N; Maier LS; Olivotto I
BMC Cardiovasc Disord; 2020 Dec; 20(1):516. PubMed ID: 33297970
[TBL] [Abstract][Full Text] [Related]
10. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
Chiou KR; Chu CT; Charng MJ
J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
[TBL] [Abstract][Full Text] [Related]
11. A Long Term Follow-up Study of Carriers of Hypertrophic Cardiomyopathy Mutations.
McTaggart DR; Ogden KJ; Marathe JA
Heart Lung Circ; 2017 Jan; 26(1):18-24. PubMed ID: 27373729
[TBL] [Abstract][Full Text] [Related]
12. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of R403WMYH7 and R92WTNNT2 HCM families: mutations determine left ventricular dimensions but not wall thickness during disease progression.
Revera M; Van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC
Cardiovasc J Afr; 2007; 18(3):146-53. PubMed ID: 17612745
[TBL] [Abstract][Full Text] [Related]
14. Novel electrocardiographic features in carriers of hypertrophic cardiomyopathy causing sarcomeric mutations.
Jalanko M; Heliö T; Mustonen P; Kokkonen J; Huhtala H; Laine M; Jääskeläinen P; Tarkiainen M; Lauerma K; Sipola P; Laakso M; Kuusisto J; Nikus K
J Electrocardiol; 2018; 51(6):983-989. PubMed ID: 30497761
[TBL] [Abstract][Full Text] [Related]
15. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
[TBL] [Abstract][Full Text] [Related]
16. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
[TBL] [Abstract][Full Text] [Related]
17. Global and regional echocardiographic strain to assess the early phase of hypertrophic cardiomyopathy due to sarcomeric mutations.
Baudry G; Mansencal N; Reynaud A; Richard P; Dubourg O; Komajda M; Isnard R; Réant P; Charron P
Eur Heart J Cardiovasc Imaging; 2020 Mar; 21(3):291-298. PubMed ID: 31056691
[TBL] [Abstract][Full Text] [Related]
18. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S
PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
